Drug interactions for the following drug(s)

Interactions between your selected drugs

The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Fluticasone.

Acetylsalicylic acid may decrease the excretion rate of Triamterene which could result in a higher serum level.

The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Triamcinolone.

The therapeutic efficacy of Furosemide can be increased when used in combination with Fluticasone propionate.

The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Furosemide.

Furosemide may increase the excretion rate of Potassium chloride which could result in a lower serum level and potentially a reduction in efficacy.

The risk or severity of hyperkalemia can be increased when Potassium chloride is combined with Triamterene.

The bioavailability of Fluticasone can be decreased when combined with Calcium carbonate.

The protein binding of Furosemide can be decreased when combined with Levothyroxine.

The bioavailability of Triamcinolone can be decreased when combined with Calcium carbonate.

Calcium carbonate can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.

Hydrochlorothiazide may decrease the excretion rate of Calcium carbonate which could result in a higher serum level.

Hydrochlorothiazide may decrease the excretion rate of Folic acid which could result in a higher serum level.

The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Triamcinolone.

The risk or severity of hyperkalemia can be increased when Potassium chloride is combined with Lisinopril.

Acetylsalicylic acid may decrease the excretion rate of Potassium chloride which could result in a higher serum level.

The risk or severity of adverse effects can be increased when Triamcinolone is combined with Acetylsalicylic acid.

furosemide<>lisinopril anhydrous

Applies to: Furosemide 20 MG Oral Tablet <> Lisinopril 5 MG Oral Tablet

The risk or severity of renal failure and hypotension can be increased when Furosemide is combined with Lisinopril.

The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Acetylsalicylic acid.

The risk or severity of increased serum creatinine can be increased when Acetylsalicylic acid is combined with Furosemide.

The metabolism of Levothyroxine can be decreased when combined with Fluticasone furoate.

The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Fluticasone.

Acetylsalicylic acid may decrease the excretion rate of Folic acid which could result in a higher serum level.

Folic acid may decrease the excretion rate of Lisinopril which could result in a higher serum level.

The risk or severity of electrolyte imbalance can be increased when Triamcinolone is combined with Hydrochlorothiazide.

The risk or severity of electrolyte imbalance can be increased when Fluticasone furoate is combined with Hydrochlorothiazide.

The risk or severity of hypokalemia can be increased when Triamcinolone is combined with Furosemide.

Furosemide may decrease the excretion rate of Folic acid which could result in a higher serum level.

The metabolism of Levothyroxine can be increased when combined with Triamcinolone.

The therapeutic efficacy of Lisinopril can be decreased when used in combination with Acetylsalicylic acid.

The risk or severity of hyperkalemia can be increased when Triamterene is combined with Lisinopril.

The therapeutic efficacy of Levothyroxine can be increased when used in combination with Acetylsalicylic acid.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Interactions between your selected drugs

Drug1 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to cholecalciferol, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Cholecalciferol and Fluticasone. Drug1 is resolved to cholecalciferol, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Cholecalciferol and Fluticasone furoate. Drug1 is resolved to cholecalciferol, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Cholecalciferol and Fluticasone propionate.

Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to triamterene and interaction asserted in DrugBank between Acetylsalicylic acid and Triamterene. Drug1 is resolved to aspirin, Drug2 is resolved to hydrochlorothiazide and interaction asserted in DrugBank between Acetylsalicylic acid and Hydrochlorothiazide.

Drug1 (rxcui = 1090641, name = triamcinolone acetonide 0.0005 MG/MG Topical Ointment, tty = SCD). Drug2 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug1 is resolved to cholecalciferol, Drug2 is resolved to triamcinolone and interaction asserted in DrugBank between Cholecalciferol and Triamcinolone.

Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Furosemide and Fluticasone propionate. Drug1 is resolved to furosemide, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Furosemide and Fluticasone.

Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to triamterene and interaction asserted in DrugBank between Furosemide and Triamterene. Drug1 is resolved to furosemide, Drug2 is resolved to hydrochlorothiazide and interaction asserted in DrugBank between Furosemide and Hydrochlorothiazide.

Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1801298, name = Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to potassium chloride and interaction asserted in DrugBank between Furosemide and Potassium chloride.

Drug1 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1801298, name = Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to potassium chloride, Drug2 is resolved to triamterene and interaction asserted in DrugBank between Potassium chloride and Triamterene. Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to potassium chloride and interaction asserted in DrugBank between Hydrochlorothiazide and Potassium chloride.

Drug1 (rxcui = 1653049, name = calcium carbonate 1177 MG Chewable Tablet [Tums], tty = SBD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to calcium carbonate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Calcium carbonate and Fluticasone. Drug1 is resolved to calcium carbonate, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Calcium carbonate and Fluticasone propionate.

Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Furosemide and Levothyroxine.

Drug1 (rxcui = 1090641, name = triamcinolone acetonide 0.0005 MG/MG Topical Ointment, tty = SCD). Drug2 (rxcui = 1653049, name = calcium carbonate 1177 MG Chewable Tablet [Tums], tty = SBD). Drug1 is resolved to calcium carbonate, Drug2 is resolved to triamcinolone and interaction asserted in DrugBank between Calcium carbonate and Triamcinolone.

Drug1 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1653049, name = calcium carbonate 1177 MG Chewable Tablet [Tums], tty = SBD). Drug1 is resolved to calcium carbonate, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Calcium carbonate and Levothyroxine.

Drug1 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1653049, name = calcium carbonate 1177 MG Chewable Tablet [Tums], tty = SBD). Drug1 is resolved to calcium carbonate, Drug2 is resolved to hydrochlorothiazide and interaction asserted in DrugBank between Calcium carbonate and Hydrochlorothiazide.

Drug1 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to hydrochlorothiazide and interaction asserted in DrugBank between Folic acid and Hydrochlorothiazide. Drug1 is resolved to cholecalciferol, Drug2 is resolved to hydrochlorothiazide and interaction asserted in DrugBank between Cholecalciferol and Hydrochlorothiazide. Drug1 is resolved to folic acid, Drug2 is resolved to triamterene and interaction asserted in DrugBank between Folic acid and Triamterene.

Drug1 (rxcui = 1090641, name = triamcinolone acetonide 0.0005 MG/MG Topical Ointment, tty = SCD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to triamcinolone, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Triamcinolone and Fluticasone propionate. Drug1 is resolved to triamcinolone, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Triamcinolone and Fluticasone. Drug1 is resolved to triamcinolone, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Triamcinolone and Fluticasone furoate.

Drug1 (rxcui = 311354, name = lisinopril 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1801298, name = Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to potassium chloride, Drug2 is resolved to lisinopril anhydrous and interaction asserted in DrugBank between Potassium chloride and Lisinopril. Drug1 is resolved to potassium chloride, Drug2 is resolved to lisinopril and interaction asserted in DrugBank between Potassium chloride and Lisinopril.

Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1801298, name = Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to potassium chloride and interaction asserted in DrugBank between Acetylsalicylic acid and Potassium chloride.

Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1090641, name = triamcinolone acetonide 0.0005 MG/MG Topical Ointment, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to triamcinolone and interaction asserted in DrugBank between Acetylsalicylic acid and Triamcinolone.

furosemide<>lisinopril anhydrous

Applies to: Furosemide 20 MG Oral Tablet <> Lisinopril 5 MG Oral Tablet

Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 311354, name = lisinopril 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to lisinopril anhydrous and interaction asserted in DrugBank between Furosemide and Lisinopril. Drug1 is resolved to furosemide, Drug2 is resolved to lisinopril and interaction asserted in DrugBank between Furosemide and Lisinopril.

Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Acetylsalicylic acid and Fluticasone propionate. Drug1 is resolved to aspirin, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Acetylsalicylic acid and Fluticasone. Drug1 is resolved to aspirin, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Acetylsalicylic acid and Fluticasone furoate.

Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to furosemide and interaction asserted in DrugBank between Acetylsalicylic acid and Furosemide.

Drug1 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Levothyroxine and Fluticasone furoate. Drug1 is resolved to levothyroxine, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Levothyroxine and Fluticasone propionate. Drug1 is resolved to levothyroxine, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Levothyroxine and Fluticasone.

Drug1 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to fluticasone, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Fluticasone and Fluticasone furoate. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Fluticasone furoate and Fluticasone. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Fluticasone propionate and Fluticasone furoate. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Fluticasone furoate and Fluticasone propionate. Drug1 is resolved to fluticasone, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Fluticasone and Fluticasone propionate. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Fluticasone propionate and Fluticasone.

Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to folic acid and interaction asserted in DrugBank between Acetylsalicylic acid and Folic acid.

Drug1 (rxcui = 311354, name = lisinopril 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to lisinopril anhydrous and interaction asserted in DrugBank between Folic acid and Lisinopril. Drug1 is resolved to folic acid, Drug2 is resolved to lisinopril and interaction asserted in DrugBank between Folic acid and Lisinopril.

Drug1 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1090641, name = triamcinolone acetonide 0.0005 MG/MG Topical Ointment, tty = SCD). Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to triamcinolone and interaction asserted in DrugBank between Hydrochlorothiazide and Triamcinolone.

Drug1 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Hydrochlorothiazide and Fluticasone furoate. Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Hydrochlorothiazide and Fluticasone propionate. Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Hydrochlorothiazide and Fluticasone.

Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1090641, name = triamcinolone acetonide 0.0005 MG/MG Topical Ointment, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to triamcinolone and interaction asserted in DrugBank between Furosemide and Triamcinolone.

Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to furosemide and interaction asserted in DrugBank between Folic acid and Furosemide.

Drug1 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1090641, name = triamcinolone acetonide 0.0005 MG/MG Topical Ointment, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to triamcinolone and interaction asserted in DrugBank between Levothyroxine and Triamcinolone.

Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 311354, name = lisinopril 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to lisinopril anhydrous and interaction asserted in DrugBank between Acetylsalicylic acid and Lisinopril. Drug1 is resolved to aspirin, Drug2 is resolved to lisinopril and interaction asserted in DrugBank between Acetylsalicylic acid and Lisinopril.

Drug1 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 311354, name = lisinopril 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to triamterene, Drug2 is resolved to lisinopril anhydrous and interaction asserted in DrugBank between Triamterene and Lisinopril. Drug1 is resolved to triamterene, Drug2 is resolved to lisinopril and interaction asserted in DrugBank between Triamterene and Lisinopril.

Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Acetylsalicylic acid and Levothyroxine.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.